It has been reported that various endocrine hormones exert prominent effects on erythropoiesis.
I
n animal circulation systems, alterations in the gene program are progressively transmitted from the expression of the so-called "fetal program" in the early developmental stages to the adult gene program. The expression of sets of programmed genes or isoforms are differentiation stage specific. For instance, the expression of the animal globin gene coincides with changes in the morphology of erythroid cells and hemoglobin composition. During the fetal-to-adult transition period, the human ␤-globin locus also progressively transitions from the expression of ␥-globin genes to the expression of ␤-and ␦-globin genes (1, 2) . There are at least 3 adult and 2 embryonic ␣-hemoglobin chain genes and 2 adult and 3 embryonic ␤-hemoglobin genes in the zebrafish (Danio rerio) genome. The major form of the embryonic ␤-hemoglobin in zebrafish is ␤-hemoglobin embryonic 1 (hbbe1). The switch from embryonic to adult Hb in zebrafish occurs 10 to 18 days post fertilization (3, 4) . No fetal Hb has been found in zebrafish. The exact composition of the zebrafish Hb tetramers and the oxygen affinities of the distinct zebrafish Hbs are unknown (3) (4) (5) . However, the conservation of the transcription factors responsible for the globin gene switch (GATA1, YY1, NR2F2, NFE2, TIEG2, and KLF1) in zebrafish and humans suggests that the regulatory mechanism underlying the embryonic-adult globin expression switch exists in many teleosts (6) .
An important clinical and experimental feature of congestive heart failure is the reactivation of a "cardiac fetal gene program", including Myh7, Acta1, and atrial natriuretic factor, in hypertrophic hearts (7, 8) . The alterations in the adult pathologic myocardium can be achieved by pressure overload, atrophy, and adrenergic agonists (7, 8) . Based on studies on mammalian myocardial disease, we demonstrated that the reactivated expression of the typical fetal cardiac gene atrial natriuretic factor in adult zebrafish ventricular cardiomyocytes is also observed when h t t p : / / i r . i h b . a c . c n the fish are treated with adrenergic agonists, such as phenylephrine (PE) and isoproterenol (ISO) (9) .
The analysis of the ISO-or PE-treated adult zebrafish revealed that the treatments can also induce the expression of embryonic globin gene hbbe1 in adult zebrafish erythrocytes. In light of this observation, the human erythroleukemia cell line K562 was utilized for further studies. Our results revealed that the adrenergic agonists PE and ISO can activate the expression of human fetal hemoglobin (HbF) in K562 cells. Our experiments also demonstrated that the acetylation levels of histone H3 and histone H4, the p38 MAPK signaling pathway, and erythropoiesis were activated in K562 cells after treatment with the adrenergic agonist. These results provide strong evidence demonstrating the regulatory roles of adrenergic agents on erythroid differentiation through the p38 MAPK pathway.
Materials and Methods

Animals, cell culture, and reagents
Phenylephrine hydrochloride (PE) and isoprenaline hydrochloride (ISO) were purchased from Tokyo Kasei Kogyo Co, Ltd and Sigma, respectively. The p38-specific inhibitor SB203580 and the antibodies against p38 MAPK, phospho-p38 MAPK, ERK1/2, histone H3, and histone H4 were purchased from the Beyotime Institute of Biotechnology. The phospho-p42/44 MAPK antibody, the human cAMP response element binding (CREB) antibody, and the phospho-CREB antibody were purchased from Cell Signaling Technology. The zebrafish hbbe1 antibody was purchased from United States Biological. The human ␥-globin and ß-actin antibodies were purchased from Santa Cruz Biotechnology. The antibodies against human CD71 and CD41 were purchased from Beijing Biosynthesis Biotechnology. The antibodies against acetyl-histone H3 (acH3) and acetyl-histone H4 (acH4), as well as KT 5720, were purchased from Millipore Corp. C646, which is a histone acetyltransferase (HAT) inhibitor, was obtained from Sigma Chemical Co.
Human erythroleukemia K562 cells were cultured in RPMI 1640 medium (Thermo Scientific Hyclone ) supplemented with 10% fetal bovine serum (Thermo Scientific Hyclone), 100 kU/L penicillin, and 100 mg/L streptomycin in a humidified atmosphere with 5% CO 2 . K562 cells at a concentration of 1 ϫ 10 5 /ml were incubated with PE (5 M or 10 M), ISO (5 M or 10 M), or SB203580 (10 M) for 4 days.
Zebrafish (Danio rerio) were maintained in dechlorinated tap water at 28.5°C with a 14-hour light/10-hour dark photoperiod and were fed brine shrimp 3 times a day. For the adrenergic agonist treatments, 16 to 22 4-month-old fish in a 4-L tank containing dechlorinated tap water were exposed to 50 M PE or ISO for 1 week with daily renewal of the exposure reagent. The control fish were maintained under same conditions and density without any exposure reagent. Anesthetized fish were wiped with a tissue and laid on a flat surface with the head to the left and the ventral side facing up. A 10-L pipette tip rinsed with heparin (3 U/mL) was inserted into the heart cavity to draw the blood with gentle suction. The blood samples were immediately transferred into PBS solution containing 1 U/ l mL heparin for Western blot assay or the TRIzol reagent (Invitrogen) for RNA extraction. All procedures relating to the care and use of fish were approved by the Ethics Committee from Institute of Hydrobiology, Chinese Academy of Sciences (Approval Protocol no.IHB20110071) in accordance with the National Guiding Principle for the Care and Use of Laboratory Animals.
RT-PCR and quantitative real-time PCR
The total RNA from the erythrocyte and K562 samples was extracted using the TRIzol reagent, treated with RNase-free DNase I for 30 minutes at 37°C, and extracted with phenol/ chloroform. A RevertAid First Strand Kit (Thermo Scientific) and oligo(dT) primers were used to synthesize cDNA in a reaction volume of 20 L. Real-time PCR was performed using the SYBR Bestar-real time PCR Master system (Toyobo) on a Rotor-GENE Q instrument (QIAGEN). ␤-Actin and ␥-globin were amplified from K562 cells using the following primers: ␤-actin forward primer, 5Ј-AAGAGCTACGAGCTACCTGAC-3Ј; ␤-actin reverse primer, 5Ј-ATGCCACAGGACTCCATGCC-3Ј; ␥-globin forward primer, 5Ј-AATGTGGAAGATGCTGGAG-GAGAA-3Ј; and ␥-globin reverse primer, 5Ј-CTTCTTGCCAT-GTGCCTTGACTT-3Ј. The zebrafish ␤-actin and hbbe1 were amplified using the following primers: ␤-actin forward primer, 5Ј-cgagcaggagatgggaacc-3Ј; ␤-actin reverse primer, 5Ј-caacggaaacgctcattgc-3Ј; hbbe1 forward primer, 5Ј-ctgatcttactcctggatca-3Ј; and hbbe1 reverse primer, 5Ј-acggagcttgaaagcgtgca-3Ј. The PCR program included the following steps: 94°C for 2 minutes and 40 cycles of 94°C for 5 seconds, 60°C for 15 seconds, and 72°C for 35 seconds. The data analysis was performed using the software supplied by the manufacturer to define the threshold cycle (Ct) at which each sample attained the threshold value. The mRNA level of each gene in each sample was first calculated in reference to the ß-actin transcript, which was amplified as an internal control, and then represented as the fold increase relative to the control samples.
Bisulfite sequence analysis
The methylation status at the promoters of the ␥-and ␤-globin genes in K562 cells was analyzed through the bisulfite treatment of the DNA as described previously (10) . A fragment of the ␥-globin gene promoter that includes the 5 CpG dinucleotides at positions Ϫ54, Ϫ51, ϩ5, ϩ16, and ϩ49 was amplified using the primers 5Ј-TTGATAAGGTAAATTTGATTAATAGTTTTA-3Ј (forward) and 5Ј-CCTCCTCTATAAAATAACCCATAA-3Ј (reverse), and a fragment of the ␤-globin gene promoter containing 3 CpG dinucleotides at positions Ϫ306, Ϫ265, and Ϫ125 was also amplified using the primers 5Ј-GTGTAATAA-GAAAATTGGGAAAA-3Ј (forward) and 5Ј-CCAACCCTA-AAATATAACTCCACA-3Ј (reverse) (11) . The PCR program was the following: 94°C for 30 seconds and 40 cycles of 94°C for 30 seconds, 50°C for 30 seconds, and 72°C for 1 minute. The PCR products were cloned in the pMD19-T vector (Takara) and transformed into Escherichia coli cells. The inserts were sequenced from at least 10 randomly selected clones.
Western blot analysis
K562 cells and adult zebrafish blood cells were rinsed twice with ice-cold PBS (1.06 mM KH 2 PO 4 , 155.17 mM NaCl, 2.97 h t t p : / / i r . i h b . a c . c n mM and Na 2 HPO 4 ⅐7 H 2 O, pH 7.4, in PBS) and before being lysed with lysis buffer (Beyotime) containing phosSTOP (Roche Diagnostics Gmbh) and a protease inhibitor cocktail (Sigma). The lysates were centrifuged twice at 13 000 ϫ g and 4°C for 10 minutes, and the supernatants were collected, and separated by SDS-PAGE, and transferred to 0.45 m PVDF membranes (Millipore). Some of blots were stripped at 50°C for 30 minutes in 100 mM 2-mercaptoethanol, 2% sodium dodecyl sulfate (SDS), 62.5 mM Tris-HCl (pH 6.7), and reprobed as indicated. The primary antibodies that used in our Western blot analyses were diluted at 1:1000 dilution were the following: anti-p38 MAPK, anti-phospho-p38 MAPK, anti-ERK1/2, anti-phospho-p42/44 MAPK, anti-CREB, anti-phospho-CREB, anti-␥-globin, and anti-ß-actin. The primary antibodies that used in our Western blot analyses were diluted at 1:500 dilution were the following: antihbbe1, anti-CD71 and anti-CD41 were 1:500 dilutions. The antibody of CD71, CD41, CREB, and phospho-CREB were diluted with the reagent of Can Get Signal Immunoreaction Enhancer Solution (Toyobo). The signal was detected by the imaging system of Alpha Innotech FluorChem Q (Alpha Innotech) with the chemiluminescence reagent (Western Blotting Luminol Reagent, Bio-Rad Laboratories).
Histone extraction and detection
K562 cells were collected by centrifugation, washed with icecold PBS, resuspended in 1 mL of ice-cold hypotonic lysis buffer (10 mM Tris-Cl [pH 8], 0.1 mM KCl, 1.5 mM MgCl 2 , and 1 mM dithiothreitol), and incubated for 30 minutes at 4°C. The lysates were centrifuged for 10 minutes at 10 000 ϫ g, and the pellet was collected, incubated with 400 L of 0.4 N HCl at 4°C for at least 1 hour, and centrifuged for 10 minutes at 16 000 ϫ g. The acidsoluble proteins in the supernatant were precipitated by the dropwise addition of 132 L of 100% trichloroacetic acid and incubated at Ϫ20°C for at least 30 minutes. After the proteins were centrifuged for at least 30 minutes at 16 000 ϫ g, the proteins were washed twice with ice-cold acetone and air dried for 5-10 minutes. The proteins were then dissolved in 50 L of distilled water, separated through 15% SDS-PAGE, and transferred to PVDF membranes for Western blotting. The primary antibodies used were antiacetylated histone 4 (acH4), antihistone 4 (H4), antiacetylated histone 3 (acH3), and antihistone 3 (H3) antibodies (all at 1:1000 dilution). A densitometric analysis with the Image J software was used to quantify the protein levels, which were normalized to the expression of histone H3 or histone H4. The data are expressed as the fold change relative to the control cells.
Benzidine staining
After treatment with PE or ISO, the K562 cells were collected, rinsed twice with ice-cold PBS, and resuspended in 0.5 mL of ice-cold PBS. One microliter of 30% hydrogen peroxide and 14 L of benzidine solution at room temperature (0.4% 3,3Ј,5,5Ј-tetramethylbenzidine in 14% acetic acid) were added to the cells. After 5 minutes, 1 L of 15% sodium nitroprusside was added to the cells. The benzidine-positive cells were visualized using a light microscope (Nikon eclipse Ti).
Flow cytometric analysis
K562 cells were collected by centrifugation, washed with icecold PBS, and resuspended in 100 L of ice-cold PBS. Approximately 5 ϫ 10 5 cells were incubated with either fluorescein isothiocyanate-conjugated CD71 or fluorescein isothiocyanateconjugated CD41 for 45 minutes on ice, washed twice with PBS, and resuspended in 0.5 mL of PBS. The treated cells were labeled with propidium iodide to separate the live cells from the dead cells, and at least 10 000 treated cells were analyzed using a Becton Dickinson FACS Aria TM III flow cytometer.
Statistics
All of the results are presented as the mean Ϯ SD. The quantitative experiments were analyzed through one-way ANOVA. Unless otherwise specified, the differences were considered to be significant if the P values were Ͻ .05. In this paper, the P values are summarized with the following symbols: -, P Ͼ .05, no statistically significant difference; *, .01 Ͻ P Յ .05, statistically significant difference; **, P Յ .01, statistically significant difference.
Results
Stimulation of embryonic hemoglobin production in adult zebrafish
Zebrafish hbbe1 is one of the major embryonic globin chains expressed during the early stages of zebrafish development (5). However, the exposure of adult zebrafish to 50 M ISO or PE for 1 week increased the expression of hbbe1 in the erythrocytes ( Figure 1A ). Western blot analyses were then employed to measure the levels of zebrafish hbbe1 protein in the blood samples. As shown in our results, the levels of zebrafish hbbe1 protein also increased significantly in the adult zebrafish erythrocytes after the fish were treated with either of the adrenergic agents (PE and IS; Figure 1B ).
Stimulation of embryonic hemoglobin production in K562 cells
The human erythroid-like K562 cell line has been extensively employed as an in vitro model for the study of the molecular mechanism(s) regulating the expression of human globin genes (12) (13) (14) (15) . Treatment with ISO (5 M or 10 M) or PE (5 M or 10 M) for 4 days significantly induced the expression of ␥-globin/HbF mRNA in K562 cells, as determined through real-time PCR (Figure 2A ). The Western blot analyses also indicated increased levels of ␥-globin protein in K562 cells after treatment with either PE or ISO ( Figure 2B ).
Effects of ISO and PE on the methylation of the ␥-globin and ␤-globin promoters
The sequencing of bisulfite-converted DNA molecules is an effective way to measure the methylation of a particular region of DNA. We utilized this approach to measure the methylation of the ␥-and ␤-globin promoters in K562 cells after treatment with the adrenergic agonists.
h t t p : / / i r . i h b . a c . c n
However, there was no difference in the methylation of the ␥-globin and the ␤-globin promoters in the K562 cells after treatment with ISO or PE. No DNA methylation was observed at Ϫ54, Ϫ51 ϩ5, ϩ16, or ϩ49 in the ␥-globin promoter region in both the treated and untreated K562 cells ( Figure 3A) . In contrast, the Ϫ306, Ϫ265, and Ϫ125 positions of the ␤-globin promoter exhibited consistently high levels of DNA methylation, regardless of treatment with the adrenergic agents ( Figure 3B ). This finding indicates that both the ISO-and the PE-induced stimulation of HbF production might not be correlated with the methylation of the ␥-globin and ␤-globin promoter regions in K562 cells.
Effects of ISO and PE on histone acetylation
The effect of ISO or PE on the level of acetylated histone proteins in K562 cells was analyzed by Western blotting using specific antibodies against acH3 and acH4. The levels of acH3 in the K562 cells increased significantly after treatment with PE, whereas the levels of both acH3 and acH4 were significantly elevated after PE or ISO treatment ( Figure 4 ). The presence of c646, which is a HAT inhibitor, in the culture media significantly suppressed the transcription of ␥-globin genes induced by the adrenergic agents (Supplemental Figure 1 published on The Endocrine Society's Journals Online web site at http://endo.endojournals.org). These results suggest that the degree of H3 and H4 acetylation might be correlated with the ISO-and PEinduced induction of HbF.
Involvements of the MAPK pathway and the cAMP-dependent pathway in the induction of HbF in K562 cells by ISO and PE
The MAPK pathways and cAMP-dependent pathways are involved in the induction of HbF by various agents, including several histone deacetylase inhibitors (16) . Therefore, the effects of ISO or PE on the p38 and ERK pathways in K562 cells were determined. As shown in Figure 5A , the level of phosphorylated p38 and ␥-globin was significantly increased in both the PE-and the ISOtreated K562 cells, whereas the treatment of the k562 cells with SB203580 and either PE or ISO almost completely abolished the PE-or ISO-induced increase in phosphorylated p38 and ␥-globin. Meanwhile, the levels of phospho- The CREB phosphorylation is significantly inhibited when the ISO and PE treatments are in the presence of SB203580 ( Figure 5A ). In contrast, both the ISO and PE treatments markedly reduced the levels of phosphorylated ERK in K562 cells ( Figure 5B) . Moreover, the ISO-and PE-induced CREB phosphorylation and ␥-globin expression in K562 cells could also be at least partially suppressed by the selective PKA inhibitor KT5720. However, significant portions of the induced CREB phosphorylation and ␥-globin expression levels in K562 cells were still observed when treated with ISO and PE, even in the presence of KT5720 (Supplemental Figure 2) . These results suggest that the activation of both the p38 signaling pathway and the cAMP-dependent pathway might be involved in the ISO-and PE-induced expression of HbF in K562 cells and that the former pathway may play a major role.
Effect of ISO and PE on K562 differentiation
Intracellular hemoglobin can be detected through the staining of cells with benzidine (12) . To monitor the accumulation of HbF after treatment with ISO or PE, we measured the hemoglobin present in the K562 cells through benzidine staining. As shown in Figure 6 , A and B, the ISO and PE treatments increased the number of benzidine-positive (hemoglobin-containing) K562 cells compared with the untreated control cells. Moreover, treatment with the p38 inhibitor SB203580 completely abolished the hemoglobin staining that was observed in the ISO-and PE-treated K562 cells ( Figure 6, A and B) . To further examine the differentiation of K562 cells after treatment with ISO or PE, CD71 and CD41, which are specific markers for erythroid precursors (14) and megakaryocytes, respectively, were utilized (17) . The levels of CD71 protein were significantly higher in the ISO-and the PE-treated K562 cell samples compared with the control cells, whereas the levels of CD41 were significantly lower in the treated samples compared with the control K562 cells ( Figure 6C ). Flow cytometric analysis showed elevated percentages of CD71-labeled cells in both the PE-and the ISO-treated samples compared with the Effects of ISO and PE on histone acetylation in K562 cells K562 cells were treated with ISO (10 M) or PE (10 M) for 4 days before being harvested and lysed. The cell lysates were analyzed by Western blotting with H3, acH3, H4, and acH4 antibodies. A, The acetylation of H3 and H4 was determined by Western blot analysis using the corresponding specific antibody. B, The Western blot for H3 acetylation was quantified by densitometric analysis using Image J. The level of H3 acetylation was normalized to the corresponding level of H3 in the sample and is expressed as the fold change relative to the level of H3 acetylation in the control sample. C, The Western blot for H4 acetylation was quantified by densitometric analysis using Image J. The level of H4 acetylation was normalized to the corresponding level of H4 in the sample and is expressed as the fold change relative to the level of H4 acetylation in the control sample. The quantification analyses were performed 3 times, and the SEs were calculated as indicated. *, P Ͻ .05; **, P Ͻ .01. 
Discussion
Previous studies have demonstrated that teleosts possess multiple globin genes that are expressed at different developmental stages (3, 5) . This phenomenon arises from the ability to produce different hemoglobins with distinct physical properties throughout development (6) . Changes in the globin gene expression are also correlated with changes in the site of hematopoiesis. Zebrafish hbbe1 is a major embryonic globin chain that exhibits 2 peaks in its expression throughout development. These peaks occur 50 -60 hours post fertilization and 72-120 hours post fertilization, are found in the intermediate cell mass and in the peripheral red blood cells, and represent the 2 waves of erythropoiesis in zebrafish embryos. After this time, definitive waves of erythropoiesis produce cells that express the zebrafish adult globins, and the globin switching occurs 10 days after fertilization (3) . Using the zebrafish model, we explored the cardiotoxic effects of adrenergic agonists on the teleost heart (9). Unexpectedly, the treatment of adult zebrafish with the adrenergic agonists ISO and PE induced elevated expression levels of the embryonic globin hbbe1 in the erythroid cells ( Figure 1A ). This up-regulation of the hbbe1 protein was also confirmed with Western blot analyses ( Figure 1B) . Unlike anucleated erythrocytes in mammals, nucleated fish red blood cells are transcriptionally active cells that can potentially respond against various stimuli (18) . Based on our RT-PCR results (Supplemental Figure 3) and previous reports (19) , many adrenergic receptor genes, such as adrenergic receptor ␣1aa, ␣1ba, ␣2a, ␤3a, and ␤3b, are expressed in zebrafish red blood cells. This finding prompted us to further explore the effects of adrenergic agonists on mammalian hemoglobin expression. Another aim of the present study was to understand the mechanisms through which adrenergic agonists modulate erythropoiesis.
K562 cells, which are a human chronic myelogenous leukemia cell line, are composed of undifferentiated erythrocytes and granulocytes. These cells can also differentiate along the erythroid and the megakaryocyte lineages. The finding that the in vitro ␥-globin mRNA and protein synthesis results obtained in these cells correlate with the in vivo ␥-globin expression results in erythrocytes suggests that the observations with K562 cells may predict in vivo responses (20) . Thus, K562 cells have been extensively employed to study the molecular mechanisms regulating the expression of HbF and to determine the potential of new differentiation-inducing compounds (13-15, 20, 21) . Quantitative PCR and Western blot analyses revealed elevated levels of both the human ␥-globin transcript and the ␥-globin protein in K562 cells treated with either PE or ISO (Figure 2, A and B) . To date, several pharmacologic agents have been shown to possess HbF-inducing activity. Many studies have focused on the role of epigenetic mod- Figure 5 . Involvement of the MAPKs in the regulation of ␥-globin expression in K562 cells after the treatment with ISO or PE A, The cell lysates were subjected to Western blot analysis using antibodies against phosphorylated p38, total p38, ␥-globin, ␤-actin, phosphorylated CREB, and CREB. The cells were treated with ISO (10 M) or PE (10 M) in the absence or presence of SB203580 (10 M). B, The cell lysates were subjected to Western blot analysis using antibodies against phosphorylated ERK1/2 and total ERK. The cells were treated with ISO (10 M) or PE (10 M). SB, SB203580. *, Statistically significant difference between the treatments in the absence or presence of SB203580 (0.01 Յ P 0.05); **, statistically highly significant difference between the treatments in the absence or presence of SB203580 (P Յ 0.01). (12, 15) . The patterns of DNA methylation are markedly different in distinct hematopoietic cells during HbF activation (12, 15) . In the present study, we measured the methylation of the ␥-and ␤-globin promoters through DNA bisulfite treatment and cloning (10, 11) . In accordance with previous reports, which found low methylation levels at the ␥-globin promoter and high methylation levels at the ␤-globin promoter (11), we did not find a significant difference in the methylation of the ␥-and ␤-globin promoters between the control K562 cells and both the ISOand the PE-treated K562 cells (Figure 3) . The comparison of the levels of histone H4 and H4 hyperacetylation through Western blot analyses with antihistone H4 and anti-acH4 antibodies revealed that the levels of acH4/H4 in K562 cells treated with the adrenergic agonists PE and ISO increased significantly compared with the controls. In addition, treatment with PE also significantly increased the hyperacetylation of histone H3 (Figure 4 ). Our results suggest that adrenergic agents can modulate the acetylation of histone 3 and histone 4 in human K562 cells. Furthermore, the addition of c646, which is a HAT inhibitor, effectively abolished the expression of ␥-globin in K562 cells induced by ISO and PE (Supplemental Figure 1) . As has been demonstrated using the histone deacetylase (HDAC)2 deficiency model and the chemical HDAC inhibitor, the inhibition of HDAC activities can also attenuate the cardiac hypertrophic growth induced by adrenergic agents, such as ISO (8) . Similar to our present results, both of these findings suggest that histone acetylation plays a significant role in the transcriptional regulation of adrenergic-regulated genes, although the exact mechanism is unclear. Several studies have suggested that p38 MAPK signaling is involved in ␥-globin expression and erythroid differentiation in K562 cells (12, 22, 23) . These findings suggest a critical role for p38 MAPK in ␥-globin activation and erythropoiesis. Both PE and ISO have been shown to effectively induce the activation of p38 MAPK in mammalian cardi- (7, 23, 24) . In K562 cells, the activation of ERK signaling leads to megakaryocytic differentiation, whereas the inhibition of the ERK pathway enhances the erythroid phenotype and the expression of ␥-globin mRNA (25) . In addition, the ERK pathway inhibitor U0126 was reported to induce ␥-globin expression and HbF formation in human erythroid progenitor cells (26) . In our present study, we verified that the adrenergic agonists PE and ISO triggered the p38 pathway and inhibited the ERK pathway to up-regulate the synthesis of HbF in K562 cells. The inhibition of p38 MAPK activation with the chemical inhibitor SB203580 markedly attenuated the induction of HbF by the adrenergic agonists. Similar results were obtained with the induction of HbF expression in K562 cells by hydroxyurea and cucurbitacin D (21) . The transcription factor CREB is the target of a variety of signaling pathways that mediate the cellular responses to extracellular stimuli, which may result in proliferation and differentiation. Several signaling pathways, such as protein kinase A (PKA), protein kinase C, Ca 2 ϩ/calmodulin-dependent kinases, stress-activated protein kinase/c-Jun N-terminal kinase, p38, and ERK MAPK, can activate CREB through its phosphorylation at serine 133 (27) . It has been suggested that the activation of cAMP-sensitive pathways, such as the protein kinase A pathway, is not sufficient for the induction of ␥-globin expression in K562 cells (28) . However, it has been reported that the induction of ␥-globin could be achieved by histone deacetylase inhibitors through the activation of CREB by the p38 signaling pathway (16) . In the presence of KT5720, which is a selective inhibitor of PKA, we observed decreased levels of inductive phospho-CREB and ␥-globin in K562 cells after treatment with ISO and PE. However, significant portions of the ISO-and PE-enhanced levels of phospho-CREB and ␥-globin in K562 cells were still observed in the presence of KT5720 (Supplemental Figure 2) . In contrast, SB203580, which is a selective inhibitor of p38, almost completely abolished the induction of the inductive levels of ␥-globin in both ISO-and PE-treated K562 cells ( Figure  5A ). These results suggest that the inductive effects of ISO and PE on ␥-globin in K562 cells are mainly mediated by the activation of CREB through p38 signaling, although the PKA signaling pathway may also be involved.
HbF expression is nearly completely silenced in mammals during the first year of postnatal life. However, significant elevations in HbF in adult humans are associated with times of extremely stressed erythropoiesis, such as recovery from bone marrow ablation during transplantation (29) . It was previously demonstrated that some adrenergic agonists (epinephrine, norepinephrine, and ISO) have a clear stimulatory effect on the growth of primitive erythroid precursors in normal human bone marrow (30) . CD71 (the transferrin receptor) is expressed on all proliferating hematopoietic cells and highly expressed in early erythroid progenitors (31) . The present results also demonstrated that treatment with an adrenergic agonist (PE or ISO) effectively induced the differentiation of K562 cells into human hematopoietic progenitors (CD71-positive cells) (Figure 6 ). This finding indicates that treatment with an adrenergic agonist favors erythroid differentiation, which results in the production of more erythroid cells that predominantly synthesize HbF.
Some synthetic adrenergic agents are commonly used to treat various clinical conditions. However, information on the effects of various adrenergic agents on the regulation of globin gene expressions and erythropoiesis is generally lacking. It has been reported that PE and ISO exert growth-promoting effects in K562 cells under different culture conditions (32) . Recently, Fuchs et al (33) reported that 2 of the ␣1-adrenergic antagonists, namely benoxathian and prazosin, can inhibit the growth of K562 cells and promote the differentiation of the cells toward the megakaryocyte lineage, as determined through the increased levels of CD41 expression. This observation is in line with our present results ( Figure 6 , C and D): the adrenergic agonists PE and ISO promote erythroid differentiation and inhibit megakaryocyte differentiation in K562 cells. However, Fuchs et al (34) later observed that the treatment of K562 cells with the ␣-adrenergic agonist naphazoline (NAPH) resulted in the inhibition of both the growth and erythroid differentiation of the cells. The treatment of K562 cells with NAPH at concentrations of 100 M for 4 days resulted in slightly increased levels of ␥-globin mRNA. In addition, treatment with 200 M NAPH for 4 days resulted in severe apoptosis. In general, we observed that the treatment of K562 cells with NAPH resulted in a relatively high level of toxicity compared with PE and ISO. Thus, we hypothesize that the effects of the different synthetic adrenergic agonists on the erythroid differentiation of K562 cells may depend on the combination of the specific selectivity, receptor affinity, and cytoxicity of each compound. At present, it is unclear whether the fetal globin induction effect of PE or ISO is adrenergic receptor dependent. The ␤-adrenergic receptor has been detected in K562 cells (http://www.abcam.com/ beta-3-adrenergic-Receptor-antibody-ab76249.html), but the expression of the ␣-adrenergic receptor has not been found in these cells (34) . PE is generally accepted as an ␣-adrenergic receptor agonist (35) , whereas ISO is a commonly used ␤-adrenergic agonist (36) . However, the cross-stimulation between the ␣-adrenergic agonist PE and the ␤-adrenergic receptor has been reported under certain conditions (37, 38) . Therefore, the precise mechanisms through which h t t p : / / i r . i h b . a c . c n adrenergic signaling induces erythroid differentiation require further investigation.
Over the last 4 decades, considerable efforts have been devoted to the pharmacologic induction of HbF in patients with ␤-globin disorders. A number of different classes of agents, including hypomethylating and cytotoxic drugs, such as 5-azacytidine and hydroxyurea, histone deacetylase inhibitors, such as sodium butyrate, DNA-binding drugs, such as tallimustine and mithramycin (1, 20, 39) , and cytokines, such as erythropoietin, stem cell factor, and TGF-␤ (40), have been employed to induce the expression of HbF in cell or animal models. Of these agents, HU has already been approved for the treatment of patients with moderate and/or severe sickle cell disease (39) . However, studies have also shown that only some patients respond to these drugs with an increased HbF production due to individual genetic determinants that influence HbF production (1, 39) . The results of these previous clinical studies highlight the complex mechanisms that regulate globin gene expression and suggest that a combination therapy consisting of 2 or more drugs with different mechanisms of action would induce higher levels of HbF than treatment with a single agent. Thus, the need for more effective, safer HbF-inducing agents is clear. A better understanding of the mechanisms regulating HbF expression and the development of more effective agents may address the unique aspects of the pathophysiology of ␤-thalassemias to yield therapies that are customized for each individual patient.
Although adrenergic agonists have previously been reported to have diverse biological activities, particularly with respect to the cardiovascular system or asthma treatments (35, 36, 41) , no previous study has investigated the effects of PE or ISO on HbF induction. Thus, we identified a novel effect of adrenergic agonists: their ability to induce HbF expression in the K562 cell line and zebrafish. These findings also provide evidence that hemoglobin genes and erythropoiesis may be regulated by adrenergic hormonal signals. Our data should encourage other researchers to investigate the effects of PE, ISO, and other structurally related adrenergic agonists on experimental animals and progenitor erythroid cells to determine conclusively the potential use of such agents for the treatment of hematologic diseases.
